Latino Semaglutide Study
Completed · Phase 3 · Has a placebo group
Conditions studied: Obesity, Obesity; Drug, Overweight or Obesity, Weight Loss, Weight Loss Trajectory, Weight, Body
In brief
The purpose of this study to understand better how this anti-obesity medication works to assist individuals to lose weight and maintain weight loss. This study may lead to the development of other related medications for assisting people with the disease of obesity.
Key facts
- Study ID
- NCT05087342
- Run by
- Loma Linda University
- People needed
- 119
- Starts
- 2022-12-13
- Expected to finish
- 2024-05-29
- Last updated by the study team
- 2024-10-15
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Self-identify as being of Hispanic/Latino ethnicity
- BMI >30
- Age 18-75 years old
- Able to provide informed consent before any trial related activities
You may not qualify if…
- Current cancer treatment
- Diabetes, Type 1 or Type 2
- Eating disorders
- Medication use targeting the GPL-1 system
- In the last 30 days, attempted to lose weight by lifestyle modification alone or with the use of anti-obesity medications resulting in more than 5 pounds of weight loss.
- History of bariatric surgery
- Use of obesogenic medications (including but not limited to steroids, haloperidol, clozapine, risperidone, olanzapine, amitriptyline, imipramine, paroxetine, and lithium) which cannot be substituted or stopped.
- Pregnant or planning to become pregnant in the next 8 months
- Genetic disorders and/or physical or mental handicaps that would limit participation in the study and/or the intensive lifestyle intervention.
- Any contraindication to semaglutide 2.4 mg including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndrome Type 2, hypersensitivity to semaglutide 2.4 mg or any product components.
- Any known or suspected allergy to semaglutide 2.4 mg or related products
- Previous participation in this trial, either initial screening or group randomization
Where it is running
- Loma Linda University Health — Loma Linda, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.